Clinical Trial Update: : TRANSITION: An Observational Study of Transition From Lumacaftor/Ivacaftor to Tezacaftor/Ivacaftor (Tez/Iva)

View source ↗

Summary

Observational study assessing transition from Lumacaftor/Ivacaftor to Tezacaftor/Ivacaftor in cystic fibrosis patients; completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Lumacaftor/Ivacaftor
• Tezacaftor/Ivacaftor (Tezacaftor/ivacaftor)

Snippet

Sponsor: National Jewish Health | Conditions: Cystic Fibrosis (CF) | Status: COMPLETED | Results posted: 2021-10-01